In AML, miR-26a directly regulates the expression of the E2F7 protein, a transcriptional repressor of the cyclin-dependent kinase inhibitor p21CIP1/WAF1 (also known as CDKN1A) [24] (Figure 1B). This evidence concerns the gene E2F7 and acute myeloid leukemia.